Acelrx Pharmaceuticals reported $8.64M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.64M 54K
Acura Pharmaceuticals ACUR:US 523K 138K
Baxter International BAX:US $ 630M 18M
Becton, Dickinson and BDX:US $ 1.33B 95M
Biodelivery Sciences International BDSI:US $ 25.47M 311K
Cara Therapeutics CARA:US $ 5.88M 262K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Johnson & Johnson JNJ:US $ 6B 73M
Pain Therapeutics PTIE:US $ 1.71M 475K
Pfizer PFE:US $ 2.73B 61M
Smiths SMIN:LN 248M 26M
Teva Pharmaceutical TEVA:IT 864M 32M
Xeris Pharmaceuticals Inc XERS:US $ 24.24M 1.69M
Zogenix ZGNX:US $ 39.56M 5.68M